Fabius, I hear you loud and clear. I admit my mistakes. Back in March, they had 600k left and I was probably the biggest advocate saying, I felt he was going to ink a deal rather than dilute. All the signs were there. They put out the PR saying he had offers for Regabatin to consider, they intended to sign before mid year. It only made sense to ink a deal rather than dilute. And what did he do? He diluted LOL
So, I do have caution here, however this time is different. He has less money available. He still has not diluted. He called a special meeting to be able to do a RS and 1 week later they still have not. WHY NOT? That is the question.
So while he may have got some revenue in from MNK to bridge the gap it surly was not that substantial. so they still need to raise money. likewise they still need to meet NASDAQ requirements. so why not do the RS?
The only thing I keep going back to is something is in the works. what? I have no clue but it could be a multitude of possibilities. Even inking that deal for Regabatin, even with no upfront payment, would make sense. the price would pop to maybe $1 on news of a deal. THEN he could dilute and not need to dilute such a high percentage of the company then do the RS and know he only needs a 5 to 1 rather than 10 or 15.
so that is just one possibility but make no mistake, something is up because based on what we do know, there is a reason why he has not diluted and done the RS yet.
